One of the biggest public growing threat called mosquito-borne infections is booming worldwide with over one million deaths every year. Infections transmitted through travels and environmental changes possess a strong impact and has increased considerably over the years. Mosquito-borne infections are caused by bacteria, viruses, or parasites transmitted by mosquitoes. Mosquito-borne infections testing is generally differentiated based on the type of infections namely: mosquito-borne infections testing for dengue, mosquito-borne infections testing for zika virus, mosquito-borne infections testing for chikungunya, and mosquito-borne infections testing for malaria. Mosquito-borne infections testing is considered as the primary mode of diagnosis for mosquito-borne infections. Mosquito-borne infections testing is easily available at healthcare facilities. There are multiple mosquito-borne infections which show similar symptoms like muscle and joint pain and febrile illness.
Mosquito-borne infections Testing Market: Drivers and Restraints
The increasing prevalence of malaria, dengue and chikungunya are anticipated to be the prime factor in boosting the growth of the global mosquito-borne infections testing market over the forecast period. The incidence of dengue has grown dramatically across the globe in recent years. According to WHO, the number of cases increased from 2.2 million in 2010 to 3.2 million in 2015. Furthermore, growing infections surveillance efforts undertaken by U.S. Food and Drug Administration (FDA) and U.S. Department of Health and Human Services (HHS) is expected to fuel the market for mosquito-borne infections testing in the U.S. However, lack of awareness in low middle-income economies is expected to hamper the growth of the global mosquito-borne infections testing market. Lack of awareness can be concerning for individuals who are more susceptible to infections. Vector Disease Control International (VCDI) spread awareness throughout the U.S. about the dangers of mosquito-borne infections and importance of mosquito-borne infections testing. These all factors are responsible in boosting and hampering the growth of the global mosquito-borne infections testing market.
Mosquito-borne infections Testing Market: Regional Outlook
On the basis of geography, the global mosquito-borne infections testing market is segmented into eight key regions, namely North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding China and Japan, China, Japan, and Middle East & Africa. North America is expected to contribute the maximum market share in the global mosquito-borne infections testing market due to the continuous spread of mosquito-borne infections. According to the CDC, the number of mosquito-borne infections rose from 4,858 in 2004 to 47,461 in 2016 in the U.S. Also, there was a great rise in 2016 when 41,680 Zika virus cases were reported. Latin America mosquito-borne infections testing the market and the Middle East & Africa mosquito-borne infections testing market is expected to contribute significant market share in the global mosquito-borne infections testing the market.
Mosquito-borne infections Testing Market: Key Players
Examples of some of the key players in the global mosquito-borne infections testing market are InBios International Inc, NovaTec Immundiagnostica GmbH, Abbott Laboratories, Abnova Corporation, Thermo Fisher Scientific Inc, Certest Biotech SL, F. Hoffmann-La Roche Ltd, OriGene Technologies Inc, Quest Diagnostics, and others.
To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-8636
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size.
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
The regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia-Pacific Excluding China and Japan (India, ASEAN, Australia & New Zealand)
- China
- Japan
- The Middle East and Africa (GCC, S. Africa, N. Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Mosquito-borne infections Testing Market: Segmentation
The global mosquito-borne infections testing market is segmented by test type, indication, end users and region:
Based on test type, the global mosquito-borne infections testing market is segmented into:
- Molecular Diagnostics
- Immunoassay Systems
- ELISA
- Rapid Tests
- Blot Systems And Evaluation Software
- Microspot Array Diagnostics
Based on indication, the global mosquito-borne infections testing market is segmented into:
- Malaria
- Zika Virus
- Chikungunya
- Dengue
- Others
Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-8636
Based on end users, the global mosquito-borne infections testing market is segmented into:
- Hospitals and Clinics
- Private Commercial Laboratories
- Academic and Research Centers
- Others